Abstract
The sand flea Tunga penetrans is one of the zoonotic agents of tungiasis, a parasitic skin disease of humans and animals. The dog is one of its main reservoirs. This negatively controlled, randomized, double-masked clinical trial evaluated the therapeutic and residual efficacy of fluralaner for treatment of dogs naturally infested with T. penetrans. Sixty-two dogs from an endemically affected community in Brazil were randomly assigned to either receive oral fluralaner (Bravecto chewable tablets) at a dose of 25 to 56 mg fluralaner/kg body weight, or no treatment (31 dogs per group). Dogs were clinically examined using a severity score for acute canine tungiasis (SCADT), parasitological examinations as defined by the Fortaleza classification, and pictures of lesions on days 0 (inclusion and treatment), 7 ± 2, 14 ± 2, 21 ± 2, 28 ± 2, 60 ± 7, 90 ± 7, 120 ± 7 and 150 ± 7. The percentage of parasite-free dogs after treatment was >90% between days 14 and 90 post-treatment with 100% efficacy on study days 21, 28 and 60. Sand flea counts on fluralaner treated dogs were significantly lower (p<0.025) than control dogs on all counts from day 7 to 120. The number of live sand fleas on treated dogs was reduced by > 90% on day 7, > 95% on days 14 and 90, and 100% from day 21 to 60, and with a significant difference between groups from day 7 to 120. From day 7 to day 120, mean SCADT scores were significantly reduced in treated dogs with a mean of 0.10 compared to 1.54 on day 120 in untreated dogs. Therefore, a single oral fluralaner administration is effective for treating and achieving long lasting (> 12 weeks) prevention for tungiasis in dogs.
Funder
Merck Sharp and Dohme Animal Health GmbH
Bahia State Research Support Foundation (FAPESB) and the State University of Santa Cruz
State University of Santa Cruz
Coordination for the Improvement of Higher Education Personnel - Brazil
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference43 articles.
1. Revision on tungiasis: Treatment options and prevention;J. Heukelbach;Expert Review Anti Infect Ther,2006
2. Tungiasis: A poorly documented tropical dermatosis;M Lefebvre;Med Mal Infect,2011
3. Therapy of tungiasis: A double-blinded randomized controlled trial with oral ivermectin;J Heukelbach;Mem Inst Oswaldo Cruz,2004
4. Tungíase em uma área de aglomerado subnormal de Natal-RN: prevalência e fatores associados;M Bonfim W de;Epidemiol Serv Saúde,2010
5. Invited review—Tungiasis;J. Heukelbach;Rev Inst Med Trop S Paulo,2005
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献